Needle-based confocal laser endomicroscopy for real-time granuloma detection.
Tess Kramer, Lizzy Wijmans, Saskia van Heumen...
https://pubmed.ncbi.nlm.nih.gov/37562791/Actively Recruiting
Led by Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) · Updated on 2026-04-07
208
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are evaluating whether adding needle-based confocal laser endomicroscopy nCLE imaging to standard diagnostic bronchoscopy improves the ability to diagnose suspected malignant peripheral lung nodules. This trial addresses the challenge of diagnosing lung lesions that are difficult to see with regular bronchoscopy, aiming to increase the rate of definitive diagnosis by providing real-time microscopic imaging during tissue sampling. Participants will undergo bronchoscopy that includes standard techniques such as radial endobronchial ultrasound r-EBUS and may include fluoroscopy, electromagnetic navigation, virtual bronchoscopy, or ultrathin scopes. The study compares two groups one receiving conventional bronchoscopy with nCLE imaging integrated before transbronchial needle aspiration TBNA to guide needle placement, and a control group receiving conventional bronchoscopy without nCLE. Needle positioning may be adjusted based on nCLE feedback in the study arm to potentially improve diagnostic yield. During the study, participants will have tissue samples collected via bronchoscopy with or without nCLE guidance. Researchers will evaluate diagnostic yield, sensitivity, procedure duration, needle repositioning frequency, fluoroscopy exposure, and complication rates. Follow-up is planned up to six months after bronchoscopy to assess diagnostic outcomes and need for additional diagnostics. The total anticipated study duration is about two years, with ongoing monitoring of safety and diagnostic effectiveness.
CONDITIONS
Confocal Laser Endomicroscopy VERification
S
Saskia van Heumen, MSc
J
Jouke Annema, Prof. dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Lead Sponsor
Mauna Kea Technologies
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | nCLE Device-Assisted Bronchoscopy | Conventional Diagnostic Bronchoscopy |
|---|---|---|
| What it is | Needle-based confocal laser endomicroscopy (nCLE) uses a miniature in vivo imaging probe inserted through the TBNA needle during bronchoscopy to visualize cellular structures in peripheral lung lesions, aided by fluorescein contrast and analyzed via the Cellvizio system. | Conventional diagnostic bronchoscopy uses navigation technologies (r-EBUS, fluoroscopy, electromagnetic navigation, virtual bronchoscopy, ultrathin scope) to locate and sample peripheral lung lesions, without real-time cellular imaging. |
| Primary use | The nCLE device is used to support real-time diagnosis of peripheral malignant lung lesions by providing microscopic imaging during bronchoscopy to potentially improve diagnostic accuracy. | Conventional bronchoscopy is used to diagnose peripheral lung nodules by sampling lesions using standard navigation and tools, aiming to obtain sufficient tissue for histopathological diagnosis. |
| How it is given or performed | During bronchoscopy under general anesthesia, the nCLE probe is inserted through the TBNA needle into the lesion after administration of intravenous fluorescein, generating real-time microscopic images before tissue sampling. | Conventional bronchoscopy is performed under general anesthesia with navigation to peripheral lesions using r-EBUS and other guidance tools. Lesion sampling is completed via transbronchial needle aspiration or biopsy without real-time imaging. |
| Evidence status | Ongoing multicenter randomized trial evaluating nCLE for peripheral malignancy diagnosis. Prior studies demonstrate nCLE identifies real-time cellular patterns and may improve lesion detection, but definitive diagnostic yield, sensitivity, and impact on diagnostic workflow await results from randomized controlled trials in peripheral lung cancer. | Conventional bronchoscopy with advanced navigation is established as the standard diagnostic approach for peripheral lung nodules. Diagnostic yield varies by lesion size, location, and operator expertise, and current guidelines endorse bronchoscopy with r-EBUS and navigation for tissue diagnosis. |
| Important limitations | Fluorescein contrast poses allergy and risk of adverse reactions; nCLE requires additional equipment and technical expertise, potentially increasing procedure complexity and duration. Current evidence is insufficient to determine impact on diagnostic yield or safety in randomized settings. | Conventional bronchoscopy may have limited diagnostic yield for small or deeply located peripheral lung nodules. Operator-dependent navigation and lesion localization remain ongoing challenges and may necessitate repeat procedures or additional sampling. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of bronchoscopy procedure
Participants undergo diagnostic bronchoscopy with or without the addition of needle-based confocal laser endomicroscopy (nCLE) to analyze peripheral lung nodules.
1 procedure visit (in-person)
Duration - Up to 6 months
Participants are followed for up to 6 months after bronchoscopy to assess diagnostic outcomes and any additional diagnostics needed.
Follow-up visits as needed during 6 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Tess Kramer, Lizzy Wijmans, Saskia van Heumen...
https://pubmed.ncbi.nlm.nih.gov/37562791/Anil Vachani, Fabien Maldonado, Balaji Laxmanan...
https://pubmed.ncbi.nlm.nih.gov/34506792/Saskia van Heumen, Tess Kramer, Daniël A Korevaar...
https://pubmed.ncbi.nlm.nih.gov/38964802/Lizzy Wijmans, Joey Yared, Daniel M de Bruin...
https://pubmed.ncbi.nlm.nih.gov/31023849/Christopher J Manley, Tess Kramer, Rohit Kumar...
https://pubmed.ncbi.nlm.nih.gov/36535801/Tess Kramer, Lizzy Wijmans, Martijn de Bruin...
https://pubmed.ncbi.nlm.nih.gov/34172559/Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Lead Sponsor
Mauna Kea Technologies
Collaborating Sponsor